On Air · MWS Radio · 122 BPM · Track 09b — TransplantCheck

75% never referred. Built for nephrology.

MWS — DECK 01
Tempo 122 · 4 / 4 · PATTERN — A
Space play/stop   1–5 trigger pads   click the DJ
Scroll for the rest of the set
TransplantCheck
In plain English

TransplantCheck is Mental Wealth Solutions' patient-navigation platform for end-stage renal disease (ESRD) populations and transplant programs. It supports pre-transplant psychosocial readiness assessment and post-transplant adherence tracking. 75% of eligible ESRD patients are never referred for transplant evaluation — TransplantCheck is the front door they were never given.

75%
ESRD patients never referred
USRDS 2024 Annual Data Report
3–6 wk
Go-live window
Standard nephrology EHR integration scope
BAA
Executed AWS + Vertex AI
FHIR R4 endpoints per tenant
The problem

Seventy-five percent never referred.

75% of eligible ESRD patients are never referred for transplant. Not because clinicians don't care — because the system has no front door. The psychosocial readiness assessment is a PDF in a binder. The referral loop has no telemetry. Patients fall off between dialysis and transplant evaluation without anyone seeing it happen.

How it closes the loop

Readiness, referral, adherence.

  • Patient-facing readiness workflows.
  • Clinician-facing psychosocial assessment with embedded validated instruments.
  • Closed-loop referral with timestamped delivery, accepted-by confirmation, and measurable cycle time.
  • Post-transplant adherence tracking with branch logic for organ type.
Who it's for

The teams upstream of the OR.

Nephrology program directors. Transplant program psychosocial leads. Dialysis center medical directors. ESRD networks.

How it deploys

Three to six weeks.

Same five-step path as HealthcareCheck. Average go-live is 3–6 weeks depending on EHR integration scope (most nephrology programs want a deeper integration than FQHCs do).

Proof

Built alongside a working dialysis unit.

  • BAA executed.
  • FHIR R4 endpoints.
  • Patent-pending architecture.
  • Built alongside a working dialysis unit.

Common questions

  1. 01 Is this only for transplant centers?

    No — most of the value is upstream, in the dialysis unit where the referral never happens.

  2. 02 Does it support pediatric ESRD?

    The MVP is adult-focused. Pediatric is on the roadmap.

  3. 03 FSGS-specific workflows?

    Yes. FSGS is the patent-walking use case — the founder's own clinical thread runs through it.

Book a 30-minute fit call.

Tell us where the referral loop is breaking. We'll show you what to instrument.

Book a discovery call → Visit transplantcheck.org